| Jessica J Harris, APRN | |
|
400 Massasoit Ave Ste 305, East Providence, RI 02914-2012 | |
| (401) 294-0451 | |
| (401) 294-0461 |
| Full Name | Jessica J Harris |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Psychiatric/mental Health |
| Location | 400 Massasoit Ave Ste 305, East Providence, Rhode Island |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942970710 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | RN64505 (Rhode Island) | Secondary |
| 363LP0808X | Nurse Practitioner - Psychiatric/mental Health | APRN03567 (Rhode Island) | Primary |
| Entity Name | Ricbt, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780776476 PECOS PAC ID: 7517854995 Enrollment ID: O20040301000979 |
News Archive
It is estimated that 80% of women will suffer from vaginal candidiasis at least once in their lives. In addition to superficial infections, which can be oral or vaginal and do not usually have a serious prognosis, fungi of the Candida genus can cause systemic diseases in immunocompromised individuals and these are fatal in 40% of cases.
Roche today announced that the U.S. Food and Drug Administration has provided an Emergency Use Authorization (EUA) for the LightMix Ebola Zaire rRT-PCR Test for use on patients with signs and symptoms of Ebola Zaire virus infection in conjunction with epidemiological risk factors, such as individuals traveling from West Africa.
Colorectal cancer is fairly treatable when caught early with regular screenings, but it is still the second-leading cause of cancer-related deaths in American men and the third-leading cause in women.
Excelimmune, Inc. (www.excelimmune.com) announced today that the National Institutes of Health (NIH) has awarded the company a Small Business Innovation Research (SBIR) grant to support research aimed at developing new treatments for Clostridium difficile (C. difficile) infection, employing Excelimmune's expertise in developing novel antibody therapies for human disease.
› Verified 1 days ago
| Entity Name | Optum Behavioral Care Of Connecticut Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659152726 PECOS PAC ID: 9436502879 Enrollment ID: O20240311000275 |
News Archive
It is estimated that 80% of women will suffer from vaginal candidiasis at least once in their lives. In addition to superficial infections, which can be oral or vaginal and do not usually have a serious prognosis, fungi of the Candida genus can cause systemic diseases in immunocompromised individuals and these are fatal in 40% of cases.
Roche today announced that the U.S. Food and Drug Administration has provided an Emergency Use Authorization (EUA) for the LightMix Ebola Zaire rRT-PCR Test for use on patients with signs and symptoms of Ebola Zaire virus infection in conjunction with epidemiological risk factors, such as individuals traveling from West Africa.
Colorectal cancer is fairly treatable when caught early with regular screenings, but it is still the second-leading cause of cancer-related deaths in American men and the third-leading cause in women.
Excelimmune, Inc. (www.excelimmune.com) announced today that the National Institutes of Health (NIH) has awarded the company a Small Business Innovation Research (SBIR) grant to support research aimed at developing new treatments for Clostridium difficile (C. difficile) infection, employing Excelimmune's expertise in developing novel antibody therapies for human disease.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jessica J Harris, APRN 74 Village Grn N Apt D, Riverside, RI 02915-3927 Ph: (804) 304-3981 | Jessica J Harris, APRN 400 Massasoit Ave Ste 305, East Providence, RI 02914-2012 Ph: (401) 294-0451 |
News Archive
It is estimated that 80% of women will suffer from vaginal candidiasis at least once in their lives. In addition to superficial infections, which can be oral or vaginal and do not usually have a serious prognosis, fungi of the Candida genus can cause systemic diseases in immunocompromised individuals and these are fatal in 40% of cases.
Roche today announced that the U.S. Food and Drug Administration has provided an Emergency Use Authorization (EUA) for the LightMix Ebola Zaire rRT-PCR Test for use on patients with signs and symptoms of Ebola Zaire virus infection in conjunction with epidemiological risk factors, such as individuals traveling from West Africa.
Colorectal cancer is fairly treatable when caught early with regular screenings, but it is still the second-leading cause of cancer-related deaths in American men and the third-leading cause in women.
Excelimmune, Inc. (www.excelimmune.com) announced today that the National Institutes of Health (NIH) has awarded the company a Small Business Innovation Research (SBIR) grant to support research aimed at developing new treatments for Clostridium difficile (C. difficile) infection, employing Excelimmune's expertise in developing novel antibody therapies for human disease.
› Verified 1 days ago
Michelle L Fox, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 900 Warren Ave Ste 401, East Providence, RI 02914 Phone: 401-330-2480 | |
Regina B Monteiro, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 950 Warren Ave Fl 2, East Providence, RI 02914 Phone: 401-606-1006 | |
Danielle Barry, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1 Kettle Point Ave, East Providence, RI 02914 Phone: 401-457-1500 Fax: 401-349-4373 | |
Taylor Selke, PMHNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 400 Massasoit Ave Ste 305, East Providence, RI 02914 Phone: 401-294-0451 | |
Ann Garris, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 450 Veterans Memorial Pkwy, Bldg. 4, East Providence, RI 02914 Phone: 401-435-3400 Fax: 401-435-3586 | |
Cara Beth Cavazza, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1 Office Pkwy, East Providence, RI 02914 Phone: 401-435-3325 | |
Sarah Madeline Bertsch, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1 Kettle Point Ave, East Providence, RI 02914 Phone: 401-457-1500 |